Repeated Melatonin Supplementation Improves Sleep in Hypertensive Patients Treated with Beta-Blockers: A Randomized Controlled Trial
Author(s) -
Frank A. J. L. Scheer,
Christopher J. Morris,
Joanna I. Garcia,
Carolina Smales,
Erin E. Kelly,
Jenny Marks,
Atul Malhotra,
Steven A. Shea
Publication year - 2012
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.5665/sleep.2122
Subject(s) - melatonin , medicine , sleep onset latency , placebo , polysomnography , atenolol , discontinuation , randomized controlled trial , anesthesia , sleep onset , insomnia , blood pressure , pharmacology , alternative medicine , apnea , pathology
In the United States alone, approximately 22 million people take beta-blockers chronically. These medications suppress endogenous nighttime melatonin secretion, which may explain a reported side effect of insomnia. Therefore, we tested whether nightly melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom